IMS Patient App is a mobile portal for patients to manage healthcare records, appointments, and virtual visits on iOS.
The App DNA
What makes this app unique?
It removes the administrative friction of manual office check-ins and scheduling for patients of Meditab-integrated clinics.
For Patients of healthcare providers who utilize the Meditab software suite for clinical management.
What does it look like?
Key features
Access to health records and prescription refills, driving institutional adoption.
Enables remote consultations, allowing providers to bill for virtual services.
Generates barcodes for physical office check-in, reducing administrative overhead.
How much does it cost?
The app functions as a free utility for patients, with monetization occurring through B2B licensing to healthcare providers.
Velocity
Dormant developmentopaqueShow more...
The IMS Patient App has entered a zombie state, with no updates or feature releases recorded in over a year. The last release, which focused solely on minor performance and bug fixes, occurred 396 days ago. There is no evidence of active development or ongoing maintenance for the platform.
Who built it?
Meditab Software
4 apps tracked · Medical
IMSGo
IMS Patient App
IMS CareUser Sentiment
What do users think recently?
Fresh user feedback skews upset. Users appreciate patients appreciate the ability to conduct video televisits with providers without needing to travel and barcode check-in functionality at the clinic provides a convenient experience for frequent visitors.
How are ratings & reviews evolving?
What users say, by theme
- Patients appreciate the ability to conduct video televisits with providers without needing to travel
- Barcode check-in functionality at the clinic provides a convenient experience for frequent visitors
- Frequent authentication failures and forced sign-outs prevent users from accessing their medical records
25 of 25 recent reviews analyzed · moderate confidence · Upset overall
Read the full review analysisUnlock 2 more frustration themes and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for IMS Patient App
How's the Medical market?
IMS Patient App maintains a 1.97-star rating across 60 total ratings. The lack of updates for over 13 months signals a maintenance-only posture that leaves the patient experience stagnant.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for IMS Patient App
Where is it heading?
The outlook for IMS Patient App is declining due to a prolonged lack of feature updates and persistent technical instability. Without a commitment to addressing core authentication and crash issues, the app risks losing its utility as a reliable patient portal for Meditab-using clinics.
- The 13-month release gap indicates a lack of active development, which compounds the technical debt visible in authentication failures.
- Persistent crashes on the appointments tile erode user trust, leading to lower adoption of the app's core clinical features.
The SWOT
- Integrated televisit and kiosk check-in modules provide a unified clinical workflow
- Biometric authentication integration would resolve the top requested login frustration
Next best moves
Rebuild authentication flow to include biometric support because login failures are the primary driver of negative sentiment -> improve rating baseline
+ 1 more prioritized moveThe counter-intuitive read
The app's poor rating is a B2B retention risk…
Read the full takeSince the last report: The app remains in a stagnant state with no functional changes, but the competitive assessment has sharpened to highlight the risks of institutional churn and the artificial nature of its market position.
Bottom line
Stabilizing the core authentication and appointment modules would address the technical failures currently driving the 1.97-star rating. Protecting the patient-facing experience is essential to maintaining the B2B licensing value for Meditab-using clinics.
Unlock 2 critical frictions, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store, source
Report last updated